S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in

Marquee Raine Acquisition Stock Forecast, Price & News

0.00 (0.00 %)
(As of 02/26/2021 12:00 AM ET)
Today's Range
Now: $10.85
50-Day Range
MA: $11.01
52-Week Range
Now: $10.85
Volume72,561 shs
Average Volume145,117 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
There is no company description available for Marquee Raine Acquisition Corp.

Industry, Sector and Symbol

Industry --
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable


Overall MarketRank

0.00 out of 5 stars

-- Sector

99th out of 198 stocks

-- Industry

101st out of 200 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
0.00 (0.00 %)
(As of 02/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MRACU News and Ratings via Email

Sign-up to receive the latest news and ratings for MRACU and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Marquee Raine Acquisition (OTCMKTS:MRACU) Frequently Asked Questions

What stocks does MarketBeat like better than Marquee Raine Acquisition?

Wall Street analysts have given Marquee Raine Acquisition a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Marquee Raine Acquisition wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Marquee Raine Acquisition's key competitors?

What is Marquee Raine Acquisition's stock symbol?

Marquee Raine Acquisition trades on the OTCMKTS under the ticker symbol "MRACU."

When did the company's quiet period expire?

Marquee Raine Acquisition's quiet period expired on Monday, January 25th. Marquee Raine Acquisition had issued 32,500,000 shares in its initial public offering on December 15th. The total size of the offering was $325,000,000 based on an initial share price of $10.00. During the company's quiet period, insiders and any underwriters involved in the IPO were restricted from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

Who are Marquee Raine Acquisition's major shareholders?

Marquee Raine Acquisition's stock is owned by many different retail and institutional investors. Top institutional shareholders include Park West Asset Management LLC (0.00%), Alyeska Investment Group L.P. (0.00%), Alyeska Investment Group L.P. (0.00%), Healthcare of Ontario Pension Plan Trust Fund (0.00%), TOMS Capital Investment Management LP (0.00%) and Magnetar Financial LLC (0.00%).

Which major investors are buying Marquee Raine Acquisition stock?

MRACU stock was bought by a variety of institutional investors in the last quarter, including Park West Asset Management LLC, Alyeska Investment Group L.P., Alyeska Investment Group L.P., Healthcare of Ontario Pension Plan Trust Fund, TOMS Capital Investment Management LP, Sage Rock Capital Management LP, Stevard LLC, and Magnetar Financial LLC.

How do I buy shares of Marquee Raine Acquisition?

Shares of MRACU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Marquee Raine Acquisition's stock price today?

One share of MRACU stock can currently be purchased for approximately $10.85.

This page was last updated on 2/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.